Philippe

Support launch of Kesimpta in multiple sclerosis, French affiliate’s N°1 priority
• Lead and coordinate planning & strategic projects for neuroscience business unit
• Launch excellence: set up performance KPIs, tools, follow-up, communication to top management.
• Manage change management initiatives to ensure successful adoption of new processes and technologies within commercial operations : digital and cultural transformation, customer insight projects
• Set up and implement an innovative customer solution approach to increase experience and engagement
• Lead of cross-functional teams (20 associates) for Novartis group entities projects: audit remediation plan on market research (training of 300 associates) - cost savings (-20% 22 vs. 21).

• Launch Aimovig: lead the multifunctional strategic team (marketing, market access, regulatory, medical) i.e. prepare access market dossier, align local implementation of global strategy, prepare launch readiness review, prepare commercial launch for a new dedicated field force
• Team Management (4 people): hire, organize teamwork, coach and develop people
• Shaped the market for a first-in-class game changer in migraine: built severe migraine advocacy with French Headache society, helped create 1st migraine patient association, led a public affairs plan (300k€, +100 stakeholders)
• Designed and deployed of a national omnichannel beyond the pill approaches: digital disease awareness campaign with 1st ever patient podcast in pharma, VIK Migraine Chatbot (global reach 300 million people)
• Led change management: anticipate launch scenarii, strategic plan (sales forecast, pricing, P&L, inventory receipt), lead an action plan for an out-of-pocket launch in retail pharmacies,

• Led Aimovig (migraine) launch planning and execution plan in Region Europe in collaboration with global and countries
• Coordinated the Market Research plan: Migraine qualitative & quantitative patient pathway analysis, market potential, stakeholders & patient association groups mapping
• Coordinated the optimal Go-To-Market Model deep dive top 5 countries & built sales forecast model
• Launched patient pathway project (500k€), assessing bottlenecks and capacity issues at center of excellence level (#30), identified suitable solutions to be implemented locally.

• Team Management (7 to 10 sales reps), south of France, DOM-TOM: recruit and develop people through coaching, challenge and follow local action plans, animate team, foster best practice sharing & peer coaching
• Lead change Management: manage field force reorganization at local level
• N°1 in market share (20% vs 14% national) & evolution (8% vs 4% national) = 2014 “Club Excellence” winner, best performance in Neuroscience franchise

• Lead Gilenya® in multiple sclerosis launch cross-functional action plan (sales, medical, KAM), KPIs and performance follow-up, including hospital listing • Manage sales incentives for 2 field force networks (70 sales reps) • Change Management: coach reps on new process, train people on KOL management • Create a dedicated customer service team to develop tailored-made projects based on an in-depth understanding of customer needs to ensure access and value creation

• Launch Certican and deploy heart transplantation strategy & action plan (Certican®, Myfortic®, Neoral®), KOL management, drove Advisory board, delivered Medico-Marketing projects, supported a network of 7 sales reps
• Certican® (+42%/an), Myfortic® (+13%/an)
• Launch the first patient education program in Transplantation (EDUGREFFE)

Lead of gastroenterology portfolio: Smecta®, Forlax®, Fortrans® (revenue : 124 M€)
• Launch of Smecta® new taste
• Team leader for retail pharmacies strategy
• Responsible for Artotec® (rhumatology) co-marketing with Pfizer